Montoliu-Gaya, Laia http://orcid.org/0000-0001-7684-6318
Alosco, Michael L.
Yhang, Eukyung
Tripodis, Yorghos
Sconzo, Daniel
Ally, Madeline
Grötschel, Lana
Ashton, Nicholas J.
Lantero-Rodriguez, Juan
Sauer, Mathias
Gomes, Bárbara
Nilsson, Johanna
Brinkmalm, Gunnar
Sugarman, Michael A.
Aparicio, Hugo J.
Martin, Brett
Palmisano, Joseph N.
Steinberg, Eric G.
Simkin, Irene
Turk, Katherine W.
Budson, Andrew E.
Au, Rhoda
Farrer, Lindsay
Jun, Gyungah R.
Kowall, Neil W.
Stern, Robert A.
Goldstein, Lee E.
Qiu, Wei Qiao
Mez, Jesse
Huber, Bertrand Russell
Alvarez, Victor E.
McKee, Ann C.
Zetterberg, Henrik
Gobom, Johan
Stein, Thor D.
Blennow, Kaj
Funding for this research was provided by:
University of Gothenburg
Article History
Received: 7 September 2023
Revised: 16 November 2023
Accepted: 16 November 2023
First Online: 30 December 2023
Declarations
:
: HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). KB has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, BioArctic, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Ono Pharma, Pharmatrophix, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. PRN participated in Advisory Board for Roche, Novo Nordics and Cerveau (outside submitted work). Andrew E. Budson has served on a consultant or on advisory boards for Sage Pharmaceuticals and Cognito Therapeutics and has received grant monies from Biogen, Bristol Myers Squibb, and Cyclerion. He receives publishing royalties from Elsevier and Oxford University Press. Rhoda Au serves on the scientific advisory board of Signant Health, as consultant to Biogen and has given a lecture in a symposia sponsored by Eisai. Robert A. Stern has served as a consultant to Biogen and Lundbeck. He receives royalties for published neuropsychological tests from Psychological Assessment Resources, Inc. MLA has received honorarium from the Michael J Fox Foundation for services unrelated to this study. He also receives royalties from Oxford University Press. The other authors declare no competing interests.